Difference between revisions of "SwitchAntipsychotics"
From Psychiatrienet
Line 30: | Line 30: | ||
| afk14 = RA | med14 = Rest AP| | | afk14 = RA | med14 = Rest AP| | ||
| afk15 = Da | med15 = Aripiprazole_LA | | | afk15 = Da | med15 = Aripiprazole_LA | | ||
− | | afk16 = | + | | afk16 = Di | med16 = Flupenthixol_LA| |
− | | afk17 = | + | | afk17 = Df | med17 = Fluphenazine_LA| |
| afk18 = Dh | med18 = Haloperidol_LA| | | afk18 = Dh | med18 = Haloperidol_LA| | ||
| afk19 = Do | med19 = Olanzapine_LA| | | afk19 = Do | med19 = Olanzapine_LA| |
Revision as of 18:03, 18 March 2022
Switching Antipsychotics
To see the consequences of a switch between antipsychotics click in the crosstable below:
the switch is made "from" (vertical) "to" (horizontal).
During switching: don't reduce anticholinergics; consider adding oxazepam. Read: General considerations concerning switching antipsychotics.
Rest AP = Chlorprothixene, Flupentixol, Fluphenazine Loxapine, Pericyazine, Perphenazine,Promazine, Trifluoperazine, Ziprasidone, Zuclopentixol.
Partial agonist new = Aripiprazole, Brexpiprazole, Cariprazine.
ER = extended release (Xeplion® + Trivecta® + Byannli®), LA = long acting, MA = medium acting, UC = under construction